期刊
GELS
卷 7, 期 4, 页码 -出版社
MDPI
DOI: 10.3390/gels7040203
关键词
p(NIPAM)-co-5%AA microgels; folic acid; doxorubicin; cancer
资金
- Horizon 2020 project Future Formulations: Developing Future Pharmaceuticals Through Advanced Analysis and Intersectoral Exchange [691128]
- University of Palermo [R4D15-P8MSRI07_MARGINE]
The study successfully utilized a novel design of p(NIPAM) microgels to specifically target cancer cells while avoiding healthy cells, leading to successful drug release. Through a series of experiments and analyses, the feasibility and effectiveness of this approach were confirmed.
Over the past several decades, the development of engineered small particles as targeted and drug delivery systems (TDDS) has received great attention thanks to the possibility to overcome the limitations of classical cancer chemotherapy, including targeting incapability, nonspecific action and, consequently, systemic toxicity. Thus, this research aims at using a novel design of Poly(N-isopropylacrylamide) p(NIPAM)-based microgels to specifically target cancer cells and avoid the healthy ones, which is expected to decrease or eliminate the side effects of chemotherapeutic drugs. Smart NIPAM-based microgels were functionalized with acrylic acid and coupled to folic acid (FA), targeting the folate receptors overexpressed by cancer cells and to the chemotherapeutic drug doxorubicin (Dox). The successful conjugation of FA and Dox was demonstrated by dynamic light scattering (DLS), Fourier-transform infrared (FTIR) spectroscopy, thermogravimetric analysis (TGA), UV-VIS analysis, and differential scanning calorimetry (DSC). Furthermore, viability assay performed on cancer and healthy breast cells, suggested the microgels' biocompatibility and the cytotoxic effect of the conjugated drug. On the other hand, the specific tumor targeting of synthetized microgels was demonstrated by a co-cultured (healthy and cancer cells) assay monitored using confocal microscopy and flow cytometry. Results suggest successful targeting of cancer cells and drug release. These data support the use of pNIPAM-based microgels as good candidates as TDDS.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据